MEI Pharma, Inc. (MEIP)
NASDAQ: MEIP · Real-Time Price · USD
2.800
-0.060 (-2.10%)
Nov 20, 2024, 4:00 PM EST - Market closed
MEI Pharma Employees
MEI Pharma had 28 employees as of June 30, 2024. The number of employees decreased by 18 or -39.13% compared to the previous year.
Employees
28
Change (1Y)
-18
Growth (1Y)
-39.13%
Revenue / Employee
n/a
Profits / Employee
-$1,664,393
Market Cap
18.66M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Concord Medical Services Holdings | 727 |
ProPhase Labs | 113 |
American Shared Hospital Services | 31 |
Palatin Technologies | 30 |
Cognition Therapeutics | 28 |
Unity Biotechnology | 19 |
NeuroSense Therapeutics | 18 |
Bullfrog AI | 11 |
MEIP News
- 8 days ago - MEI Pharma Reports First Quarter Fiscal Year 2025 Cash Position - Business Wire
- 2 months ago - MEI Pharma Reports Fiscal Year End 2024 Cash Position - Business Wire
- 3 months ago - MEI Pharma Engages Oppenheimer & Co. Inc. to Assist in Evaluating Strategic Alternatives - Business Wire
- 4 months ago - MEI Pharma to Consider Strategic Alternatives - Business Wire
- 6 months ago - Glancy Prongay & Murray LLP Announces Investigation of MEI Pharma, Inc. (MEIP) - Business Wire
- 6 months ago - MEI Pharma Reports Third Quarter Fiscal Year 2024 Results and Operational Highlights - Business Wire
- 8 months ago - MEI Pharma Board of Directors Aligns on Strategy to Advance Voruciclib and ME-344 - Business Wire
- 8 months ago - MEI Pharma Reports Initial Data from Clinical Study Evaluating ME-344 in Combination with Bevacizumab (Avastin®) in Relapsed Metastatic Colorectal Cancer Patients - Business Wire